Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07447453
Active, not recruiting Not applicable

Motivational Support for an Autonomous Exercise Program for Healthy Aging

NCT07447453 · tracked via the Priya Life Science Spain tracker
Sponsor
Hospital Universitario Getafe
Phase
Not applicable
Started
2025-04-08
Last updated
2026-09-16

Condition(s) studied

Frailty at Older Adults

Investigational drug(s) / intervention(s)

MOTIVA ecosystem

MOTIVA ecosystem: A personalized exercise plan based on the user's motivational profile and performance, without professional supervision or a caregiver.

Study summary

An effective implementation of an exercise programme such as VIVIFRAIL, in an unsupervised mode, requires a careful consideration of the patient's motivational traits and state, and the adaptation of the interventions to the current stage in the behaviour change process, as critical countermeasures to fight against abandonment and lack of compliance. A computational ecosystem with motivational support, and functional and performance assessment for an autonomous exercise programme will improve the robust and prefrail community-dwelling older adults' independence and their physical and cognitive health, while reducing healthcare utilisation.

Eligibility

Sex
ALL
Min age
70 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * 70 years of age or older. * Obtain a score of 4 or higher on the SPPB. * Be able to ambulate, with or without assistance. Exclusion Criteria: * Be unable to give consent or refuse to do so. * Be unable to understand the instructions. * Have a diagnosis of a disease or clinical condition that, in the researcher's judgment, contraindicates physical exercise.

Primary outcome measure(s)

  • MOTIVA Ecosystem — From enrollment to the end of treatment at 12 months
    Compare the number of exercises performed (#exercises per session) in each VIVIFRAIL program session to the total number of sessions (adherence) between the control and intervention groups

Trial sites (2)

FacilityCityRegionStatus
Hospital Universitario Getafe Getafe Madrid
Primary Care Madrid Madrid

More Hospital Universitario Getafe trials in Spain

Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial Recruiting

Other trials for the same condition

Effect of Micronized Creatine Monohydrate on Muscle Mass, Strength and Performance in Older Adults Submitted to Total Knee Arthroplasty Recruiting
The engAGE Project: Immersive Intergenerational Intervention to Improve Movement in Older Adults Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07447453 on ClinicalTrials.gov ↗ ← All trials in Spain